Kate was just one and very sick.  Too young to talk, too young to ask why she was in the emergency room, too young to see the shock in her parents’ faces, too young to understand the diagnoses: type 1 diabetes, too young to understand “there is no cure.”  Too young to feel any hope when the doctors said, maybe, in about a decade, we’ll hear about a potential cure.  That was January 2, 1992.

In 2002, while driving past the High Sierra and Mount Whitney and hearing her Dad say “Someday I’ll climb Whitney,”  Kate suggested: “Why don’t you do a hike-a-thon for diabetes.”   And, to mark the end of that decade since her diagnosis, we launched Kiss the Sky to Conquer Diabetes with a simple thought: “Keep climbing until we Conquer Diabetes!”
In the summer of 2002, the KTS climbing team reached the summit Mount Whitney, the tallest peak in the contiguous United States, and raised over $60,000 to help find a cure.

In 2003, news of a potential cure came with the announcement that a team at MGH/Harvard under the direction of Denise Faustman, MD, PhD and David Nathan, MD, had cured diabetes in mice. And, in 2004, KTS teamed up with The Iacocca Foundation’s Join Lee Now initiative and have been climbing to support Dr. Faustman team’s efforts to find a cure for diabetes ever since.

Since climbing Mount Whitney is 2002, KTS teams have reached the summits of Mount Rainier, Mauna Kea, Humphreys Peak, Mount Shasta, and Mount Hood and climbed in the Cordillera Real in Bolivia to raise funds to find a cure.
With the support of The Iacocca Foundation and many grassroots initiatives, including our Kiss the Sky to Conquer Diabetes, the Faustman team at Massachusetts General Hospital/Harvard Medical School, raised over $12 million and successfully completed the Phase I human clinical trials of a potential cure for type 1 diabetes. And, the Faustman team has launched the Phase II of the human clinical trials and raised over $20 million of the $25.2 million needed to fully fund these trials.

In June 2017, Dr. Faustman presented the interim results of the BCG clinical trials research at the 77th Scientific Sessions of the American Diabetes Association and reported that the vaccine could permanently reverse T1D.  With this news, we may be approaching the watershed on the journey to conquer T1D.  To mark this news, KTS' 15th year of climbing and Kate's 25th year with T1D and to #senditformurph, on July 26, 2017 the KTS team will head to Sequoia National Park to begin a 27 mile trek to cross the Great Western Divide

Join us! 

To read more on the clinical trials of BCG, click on the "NEWS" tab.  For information the "Across the Great Divide" climb, click on the "EVENTS" tab, and to help us cross the Great Western Divide and conquer T1D, please find the "DONATE" link on this page.  Every dollar donated will go to support Phase II Clinical Trials testing the ability of a generic vaccine BCG to reverse advanced Type 1 Diabetes.  We really appreciate your interest and support and can't thank you enough for joining with us as we climb for Kate and to #senditformurph.


Murphy Roberts

We'll also be climbing for Murphy ("Murph") Roberts, a member of the class of 2017 at Middlebury College. Murph was a great student and person, and an avid adventurer.  He loved to ski and hike.  Murph died while hiking in Utah in the summer of 2016.  He experienced a seizure related to his Type 1 Diabetes, which caused a fall that resulted in a series of complications.  Murphy's ski coach at Middlebury said "Murphy brought passion and intensity to all of his efforts.  His soul was happiest when he was chasing adventure, competing as a member of the ski team, supporting a teammate, or showing his spirit for Middlebury."  And Murph was passionate about finding a cure for Type 1 Diabetes.

Murphy Roberts

In Murph's honor, the Kiss the Sky team joins with the Roberts family and renews our pledge to keep climbing until we Conquer T1D.  If you would like to make a donation in Murphy's honor, please find the link on this page.  Every dollar donated will go to support Phase II Clinical Trials testing the ability of a generic vaccine BCG to reverse advanced Type 1 Diabetes.  We appreciate every dollar donated and can't thank you enough for joining with us as we #senditformurph.

Murphy Roberts